Hirokazu Uyama
- Co-authors
- Hideji NakamuraHirayuki EnomotoYorihide OkudaIchiro KawaseKenya YoshidaMorito MondenKatsuyuki AozasaYasuhiko Tomita
- Topics
- Fibroblast Growth Factor Research (6 papers)Liver Disease Diagnosis and Treatment (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Hirokazu Uyama
13 papers receiving 389 citations
Peers
Comparison fields: 5 of 49
- Molecular Biology 321
- Cancer Research 74
- Hepatology 71
- Oncology 54
- Surgery 38
Countries citing papers authored by Hirokazu Uyama
This map shows the geographic impact of Hirokazu Uyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Uyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Uyama more than expected).
Fields of papers citing papers by Hirokazu Uyama
This network shows the impact of papers produced by Hirokazu Uyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Uyama. The network helps show where Hirokazu Uyama may publish in the future.
Co-authorship network of co-authors of Hirokazu Uyama
This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Uyama. A scholar is included among the top collaborators of Hirokazu Uyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Uyama. Hirokazu Uyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 48 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 72 | |
| 6 | 87 | |
| 7 | A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus. | 4 |
| 8 | Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis. | 4 |
| 9 | 76 | |
| 10 | 43 | |
| 11 | Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells. | 38 |
| 12 | The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C. | 6 |
| 13 | 10 |
About Hirokazu Uyama
Hirokazu Uyama is a scholar working on Hepatology, Rheumatology and Reproductive Medicine, having authored 13 papers that have together received 394 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (71 citations), Cancer Research (74 citations) and Molecular Biology (321 citations). Hirokazu Uyama has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hideji Nakamura, Hirayuki Enomoto, Yorihide Okuda, Ichiro Kawase, Kenya Yoshida, Morito Monden, Katsuyuki Aozasa, Yasuhiko Tomita, Yoshihiko Hoshida and Masato Sakon. Their work appears in journals such as Gastroenterology, Clinical Cancer Research and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.